Manufacturer record
Mediguard Remedies: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
3 batches manufactured by Mediguard Remedies were declared Not of Standard Quality between May 2025 and December 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
3 records linked to Mediguard Remedies in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Paracetamol, Phenylephrine Hydrochloride, Chlorpheniramine Maleate And Sodium Citrate Suspension((Ronikold - 250 Suspension)) | MMR-543Mfg 2024-08 · Exp 2026-07 | Failed Assay (for Phenylephrine Hydrochloride IP )Assay | DTL, PuducherryState lab | Dec 2025 |
| Dextromethorphan HBR, Phenylephrine Hydrochloride, & Chlorpheniramine Maleate Syrup (Dexril syrup) | MMR-872Mfg 2025-03 · Exp 2027-02 | Failed Assay (for Phenylephrine Hydrochloride IP )Assay | DTL, PuducherryState lab | Dec 2025 |
| Entcof Syrup (Ambroxol Hydrochloride, Guaiphenesin, Terbutaline Sulphate Syrup) | MMR-344Mfg 2024-03 · Exp 2026-02 | Sample does not conform to Label claim with respect to the content of Terbutalline SulphateLabelling | Drugs Testing Laboratory, Chennai-06State lab | May 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.